Cargando…

Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome

Patients with Turner syndrome (TS) are known to be at risk for excess androgen production and virilization associated with gonadoblastoma and Y chromosome mosaicism, and excess androgens are a risk factor for the development of hepatocellular carcinoma. However, virilization and hepatocellular carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Jennifer R, Lee, Sang, Sasatomi, Eizaburo, Bookhout, Christine E, Blatt, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932469/
https://www.ncbi.nlm.nih.gov/pubmed/29732458
http://dx.doi.org/10.1210/js.2018-00017
_version_ 1783319822643232768
author Law, Jennifer R
Lee, Sang
Sasatomi, Eizaburo
Bookhout, Christine E
Blatt, Julie
author_facet Law, Jennifer R
Lee, Sang
Sasatomi, Eizaburo
Bookhout, Christine E
Blatt, Julie
author_sort Law, Jennifer R
collection PubMed
description Patients with Turner syndrome (TS) are known to be at risk for excess androgen production and virilization associated with gonadoblastoma and Y chromosome mosaicism, and excess androgens are a risk factor for the development of hepatocellular carcinoma. However, virilization and hepatocellular carcinoma have not been described in a patient with TS. A 10-year-old with nonmosaic 45,X TS presented with clitoromegaly, accelerated linear growth velocity, advanced bone age, and elevated testosterone levels as well as a second occurrence of hepatocellular carcinoma. Gonadectomy was performed, and pathology revealed hilus cell hyperplasia. Immunohistochemical staining of both the original and recurrent hepatocellular carcinoma tissues was diffusely positive for androgen receptors. After gonadectomy, testosterone levels were measurable but normal, with no further virilization; however, the liver mass continued to grow. Ovarian hilus cell hyperplasia should be considered a potential etiology for virilization in the TS population. Excess endogenous testosterone exposure in girls and women with TS may be associated with hepatocellular carcinoma expressing the androgen receptor, though normalizing testosterone levels may not lead to tumor regression in these cases.
format Online
Article
Text
id pubmed-5932469
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-59324692018-05-04 Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome Law, Jennifer R Lee, Sang Sasatomi, Eizaburo Bookhout, Christine E Blatt, Julie J Endocr Soc Case Reports Patients with Turner syndrome (TS) are known to be at risk for excess androgen production and virilization associated with gonadoblastoma and Y chromosome mosaicism, and excess androgens are a risk factor for the development of hepatocellular carcinoma. However, virilization and hepatocellular carcinoma have not been described in a patient with TS. A 10-year-old with nonmosaic 45,X TS presented with clitoromegaly, accelerated linear growth velocity, advanced bone age, and elevated testosterone levels as well as a second occurrence of hepatocellular carcinoma. Gonadectomy was performed, and pathology revealed hilus cell hyperplasia. Immunohistochemical staining of both the original and recurrent hepatocellular carcinoma tissues was diffusely positive for androgen receptors. After gonadectomy, testosterone levels were measurable but normal, with no further virilization; however, the liver mass continued to grow. Ovarian hilus cell hyperplasia should be considered a potential etiology for virilization in the TS population. Excess endogenous testosterone exposure in girls and women with TS may be associated with hepatocellular carcinoma expressing the androgen receptor, though normalizing testosterone levels may not lead to tumor regression in these cases. Endocrine Society 2018-04-13 /pmc/articles/PMC5932469/ /pubmed/29732458 http://dx.doi.org/10.1210/js.2018-00017 Text en Copyright © 2018 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Reports
Law, Jennifer R
Lee, Sang
Sasatomi, Eizaburo
Bookhout, Christine E
Blatt, Julie
Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome
title Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome
title_full Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome
title_fullStr Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome
title_full_unstemmed Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome
title_short Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome
title_sort hepatocellular carcinoma, virilization, and hilus cell hyperplasia in a girl with turner syndrome
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932469/
https://www.ncbi.nlm.nih.gov/pubmed/29732458
http://dx.doi.org/10.1210/js.2018-00017
work_keys_str_mv AT lawjenniferr hepatocellularcarcinomavirilizationandhiluscellhyperplasiainagirlwithturnersyndrome
AT leesang hepatocellularcarcinomavirilizationandhiluscellhyperplasiainagirlwithturnersyndrome
AT sasatomieizaburo hepatocellularcarcinomavirilizationandhiluscellhyperplasiainagirlwithturnersyndrome
AT bookhoutchristinee hepatocellularcarcinomavirilizationandhiluscellhyperplasiainagirlwithturnersyndrome
AT blattjulie hepatocellularcarcinomavirilizationandhiluscellhyperplasiainagirlwithturnersyndrome